SCHEMBL14272178

SCHEMBL14272178

Nc1cccc2c1CCN(Cc1ccccc1)C2

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.50
ADORA1 P30542 2/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
DHFR P00374 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SLC6A5 Q9Y345 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
HPGD P15428 1/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9537435 0.86 SIGMAR1 (0.46) PNMTMEN1KMT2A
Hydrochloric Acid SCHEMBL8330798 0.84 SIGMAR1 (0.44) PNMTMEN1KMT2A
SCHEMBL13450198 0.82 HTT (0.51) PNMTMEN1KMT2ANPC1RAB9A
SCHEMBL29644344 0.82 ACACB (0.59) PNMTMEN1KMT2ANPC1RAB9A
SCHEMBL28739031 0.82 ACACB (0.59) PNMTMEN1KMT2ANPC1RAB9A
SCHEMBL6369712 0.80 HRH3 (0.54) PNMTMEN1KMT2AKDM4EALDH1A1
SCHEMBL10978742 0.79 ACHE (0.66) PNMTMEN1KMT2AKDM4EALDH1A1
SCHEMBL31134754 0.79 ACHE (0.66) PNMTMEN1KMT2AKDM4EALDH1A1
SCHEMBL13439879 0.78 ACACB (0.50) PNMTMEN1KMT2ANPC1RAB9A
SCHEMBL12680723 0.78 ACACB (0.54) PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US disclosed
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US disclosed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US disclosed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 PNMT 3342/4885ADORA1 39/4885MEN1 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.